Isradipino capsule 5 mg. order No. 1346/2026. IGSS code 97463. Quantity 7,500.

This tender, identified by Order No. 1346/2026 and IGSS Code 97463, involves the acquisition of Isradipine capsules, specifically the 5 mg dosage, with a required quantity of 7,500 units. The Guatemalan Social Security Institute (Instituto Guatemalteco de Seguridad Social - IGSS) is the contracting entity. This tender has reached the 'Adjudicated' status, meaning a contract has been awarded to a successful bidder. The procurement method used was Direct Purchase with Electronic Offer (Compra Directa con Oferta Electrónica), pursuant to Article 43, Inciso b) of the Public Procurement Law (LCE). Isradipine is a calcium channel blocker medication used primarily to treat high blood pressure (hypertension). By relaxing blood vessels, it helps to lower blood pressure, reducing the risk of stroke, heart attack, and kidney problems. The IGSS's decision to award this contract signifies that they have selected a supplier who met the tender's requirements for quality, quantity, delivery, and potentially price. This procurement ensures the availability of Isradipine 5 mg capsules for patients within the IGSS system who require treatment for hypertension, contributing to the management of cardiovascular health among its insured population.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals and General Supplies. Located in Guatemala, Latin America, this opportunity is open to firms and consortiums.

Published through Guatecompras, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.